First Trust NYSE Arca Biotechnology Index Fund
84 hedge funds and large institutions have $648M invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 9 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 23
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
20% more capital invested
Capital invested by funds: $541M → $648M (+$107M)
6% more funds holding
Funds holding: 79 → 84 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.1% less ownership
Funds ownership: 55.61% → 54.51% (-1.1%)
66% less call options, than puts
Call options by funds: $2.74M | Put options by funds: $8.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$22.2M |
| 2 |
Morgan Stanley
New York
|
+$9.69M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.87M |
| 4 |
VF
Virtu Financial
New York
|
+$4.05M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$3.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fusion Investment Group
Pittsburgh,
Pennsylvania
|
-$3.68M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.17M |
| 3 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$3M |
| 4 |
LPL Financial
San Diego,
California
|
-$1.98M |
| 5 |
BFIC
Bedell Frazier Investment Counselling
Walnut Creek,
California
|
-$1.12M |
FBT Hedge Fund Activity: Q1 2014 in Review
84 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2014, worth a combined $648M — up 20% from $541M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new FBT positions and 9 closed out — a net gain of 5 holders — while 38 added to existing stakes and 23 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $22.2M. The largest seller was Fusion Investment Group, cutting an estimated $3.68M.
- 84 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2014, up from 79 in Q4 2013.
- Funds reported $648M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2014, up 20% quarter-over-quarter.
- 14 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2014 and 9 closed out, a net change of +5 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2014 was First Trust Advisors, an estimated $22.2M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2014 was Fusion Investment Group, an estimated $3.68M sold.
Based on aggregated 13F filings for Q1 2014.